Alzheimer's Drugs News
Drugs
> Alzheimer's DrugsAlzheimer's Drugs News is an EIN News Service for health professionals. Constantly updated news and information about health.
Latest Alzheimer's Drugs News
- Life Sciences: Researchers from Howard University, Department of Pharmacology report recent findings in life sciences 26 Nov 2009 05:15 GMT
... A new study, 'Additive protective effects of against salsolinol-induced cytotoxicity in ... approved for use in mild to moderate Alzheimer's disease. The increase in acetylcholine concentrations is ... 0.6 mM salsolinol with and without various drug pretreatments for 48 h. Nicotine (50 muM) ...
- Preventing stroke, vascular dementia 26 Nov 2009 04:32 GMT
... Posted Nov 25, 2009 @ 09:00 AM With each passing year, millions of ... from becoming worse. The U.S. Food and Drug Administration has not approved any drugs for ... the drugs used for cognitive symptoms in Alzheimer's patients seem to help. David Stanley, M.D., ...
- TLR Platform Wins Bigger Deal with Merck, While Novartis Bails 26 Nov 2009 02:55 GMT
... TLR Platform Wins Bigger Deal with Merck, While Novartis Bails Swiss ... Calif.-based Dynavax's Tolamba was shelved after the drug failed to show statistical significance over placebo ... the areas of cancer, infectious diseases and Alzheimer's disease. As part of the agreement, the ...
- Bench Press 26 Nov 2009 02:55 GMT
... Scientists Pinpoint the Interplay that Kills Insulin-Producing Cells Over time, ... offering a chance to find targets for drugs to protect those cells. The failure arises ... amyloid-beta forms the telltale clumps involved in Alzheimer's disease. Though the exact mechanism for amyloid-beta ...
- Idera: Novartis deal ends, Merck pact extended 26 Nov 2009 01:11 GMT
... Idera: Novartis deal ends, Merck pact extended NEW YORK -- Idera ... Idera will regain the rights to a drug candidate the companies had worked on. The ... be used against cancer, infectious diseases, and Alzheimer's disease. The extension will complete the contract ...
- Ailing family devastated by layoff 26 Nov 2009 05:42 GMT
... NEW BEDFORD — Applesauce and baby food are a delicacy for ... Jody said about Monea, who takes several medications for chronic asthma, acid reflux and help ... eye and in the early stages of Alzheimer's disease. The living room has become a ...
- Proximagen Neuroscience - Completion of Acquisition 26 Nov 2009 02:57 GMT
... LONDON, Nov. 24, 200i9-Further to the Company’s announcement on 30 October ... Ltd (“CBT”) and the purchase of certain drug development programmes from Biovitrum AB (“Biovitrum”) (STO: ... neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. The Company raised £50 million to ...
- Alzheimer's drug to be tested on humans 25 Nov 2009 12:34 GMT
... London, Nov 25 (ANI): A drug that has shown promise in slowing Alzheimer's disease is set to go on trial in humans. The experimental drug called dimebon ...
- Vaccines on horizon for AIDS, Alzheimer's, herpes 25 Nov 2009 17:04 GMT
... Don Ryan/Associated Press, In this Oct. 6 photo, Amparo ... as a sleepy, low-profit niche in the drug industry, this year investment in partnerships and ... perhaps seen to be more attractive than drugs,” says Dr. Stanley Plotkin, a former University ...
- Local Alzheimer's Breakthrough 25 Nov 2009 16:11 GMT
... Posted Wednesday, October 26, 2005 ; 05:00 PM | Updated ... think they have a new development in Alzheimer's Disease treatment. Researchers at the Blanchette Rockefeller ... they may have made a breakthrough in Alzheimer's treatment. The new study suggests that the drug ...
- Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vac 25 Nov 2009 13:37 GMT
... Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration ... the fields of oncology, infectious diseases, and Alzheimer's disease. As part of the agreement, the ... research and development collaboration. Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune and ...
- Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants 25 Nov 2009 13:30 GMT
... Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration ... the fields of oncology, infectious diseases, and Alzheimer's disease. As part of the agreement, the ... research and development collaboration. Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune and ...
- Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors as Vaccine Adjuvants 25 Nov 2009 18:12 GMT
... Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration ... the fields of oncology, infectious diseases, and Alzheimer's disease. As part of the agreement, the ... research and development collaboration. Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune and ...
- Idera Pharma says Novartis ending allergy collaboration, Merck extends cancer research deal 25 Nov 2009 17:30 GMT
... Idera Pharma says Novartis ending allergy collaboration, Merck extends cancer research ... Idera will regain the rights to a drug candidate the companies had worked on. The ... be used against cancer, infectious diseases, and Alzheimer's disease. The extension will complete the contract ...
- Alzheimer's: Destructive Amyloid-Beta Protein May Also Be Essential for Normal Brain Function 25 Nov 2009 10:17 GMT
... But that may be counterproductive, says Dr. Inna Slutsky of Tel Aviv ... These findings may shake the foundations of Alzheimer's research. In a new study published this ... of Alzheimer's disease, however, new, more effective drug therapies could be developed. By studying synapses ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
reuters.com:
ap.org:
msnbc.msn.com:
healthday.com:
bbc.co.uk: